mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.8 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.0082 |
0.8 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
0.009 |
0.8 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |